Related Experiment Videos
[Drug-induced liver damage from the morphologic viewpoint].
1Pathologisches Institut, Städtischen Krankenhauses im Friedrichshain, Berlin, DDR.
Gastroenterologisches Journal : Organ Der Gesellschaft Fur Gastroenterologie Der DDR
|January 1, 1990
Summary
Drug-induced liver injury involves cellular changes, from adaptive organelle alterations to necrosis. Diagnosing drug-induced hepatitis and recognizing diverse liver damage, including bile duct and vascular lesions, is crucial.
Area of Science:
- Hepatology
- Toxicology
- Pathology
Background:
- Drug-induced liver injury (DILI) is a significant clinical challenge.
- Hepatocyte damage ranges from adaptive organelle changes to irreversible necrosis.
- Accurate diagnosis of DILI is complicated by its varied presentations.
Purpose of the Study:
- To provide a comprehensive overview of drug-induced liver injury.
- To detail the spectrum of histological changes associated with DILI.
- To highlight diagnostic challenges and diverse manifestations of DILI.
Main Methods:
- Review of existing literature on drug-induced liver injury.
- Analysis of pathological changes in hepatocytes, bile ducts, and vasculature.
- Discussion of clinical and diagnostic aspects of DILI.
Main Results:
- Hepatocyte organelle changes can progress from adaptive to degenerative, leading to necrosis.
- Drug-induced hepatitis can mimic various forms of non-suppurative hepatitis.
- Bile duct lesions include cholestasis and cholangiolitis; vascular lesions and tumors can also occur.
- Prolonged drug use may lead to liver hyperplasia and neoplasia.
Conclusions:
- Drug-induced liver injury encompasses a wide range of histological alterations.
- Recognizing the diverse presentations of DILI is essential for timely diagnosis and management.
- Understanding these pathological changes aids in differentiating DILI from other liver diseases.